rs60400822

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.478-22_478-21del variant in ACADVL is an intronic variant which occurs in intron 6. The highest population minor allele frequency in gnomAD v2.1.1 is 0.2253 in the African population, which is higher than the ClinGen ACADVL Variant Curation Expert Panel threshold (≥0.007) for BA1, and therefore meets this criterion (BA1). The results from in silico splicing predictors (SpliceAI) support that this variant does not affect splicing (BP4). In summary, this variant meets the criteria to be classified as benign for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: BA1, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8337734/MONDO:0008723/021

Frequency

Genomes: 𝑓 0.065 ( 1057 hom., cov: 31)
Exomes 𝑓: 0.0078 ( 1000 hom. )

Consequence

ACADVL
NM_000018.4 intron

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel B:5

Conservation

PhyloP100: -0.514

Publications

1 publications found
Variant links:
Genes affected
ACADVL (HGNC:92): (acyl-CoA dehydrogenase very long chain) The protein encoded by this gene is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in this gene product reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
ACADVL Gene-Disease associations (from GenCC):
  • very long chain acyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACADVLNM_000018.4 linkc.478-22_478-21delCA intron_variant Intron 6 of 19 ENST00000356839.10 NP_000009.1 P49748-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACADVLENST00000356839.10 linkc.478-22_478-21delCA intron_variant Intron 6 of 19 1 NM_000018.4 ENSP00000349297.5 P49748-1

Frequencies

GnomAD3 genomes
AF:
0.0649
AC:
9861
AN:
152026
Hom.:
1049
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0272
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.0255
Gnomad NFE
AF:
0.00162
Gnomad OTH
AF:
0.0464
GnomAD2 exomes
AF:
0.0181
AC:
4552
AN:
251378
AF XY:
0.0136
show subpopulations
Gnomad AFR exome
AF:
0.224
Gnomad AMR exome
AF:
0.0132
Gnomad ASJ exome
AF:
0.0118
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00213
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00778
AC:
11379
AN:
1461780
Hom.:
1000
AF XY:
0.00692
AC XY:
5032
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.231
AC:
7747
AN:
33480
American (AMR)
AF:
0.0149
AC:
668
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0123
AC:
322
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000904
AC:
78
AN:
86254
European-Finnish (FIN)
AF:
0.0000750
AC:
4
AN:
53350
Middle Eastern (MID)
AF:
0.0291
AC:
168
AN:
5768
European-Non Finnish (NFE)
AF:
0.00114
AC:
1270
AN:
1111988
Other (OTH)
AF:
0.0186
AC:
1121
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
537
1074
1612
2149
2686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0651
AC:
9900
AN:
152144
Hom.:
1057
Cov.:
31
AF XY:
0.0624
AC XY:
4642
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.222
AC:
9223
AN:
41452
American (AMR)
AF:
0.0270
AC:
413
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10610
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.00162
AC:
110
AN:
68014
Other (OTH)
AF:
0.0459
AC:
97
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
381
762
1143
1524
1905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0283
Hom.:
5
Asia WGS
AF:
0.0150
AC:
51
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Very long chain acyl-CoA dehydrogenase deficiency Benign:3
Nov 13, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 22, 2022
ClinGen ACADVL Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The c.478-22_478-21del variant in ACADVL is an intronic variant which occurs in intron 6. The highest population minor allele frequency in gnomAD v2.1.1 is 0.2253 in the African population, which is higher than the ClinGen ACADVL Variant Curation Expert Panel threshold (≥0.007) for BA1, and therefore meets this criterion (BA1). The results from in silico splicing predictors (SpliceAI) support that this variant does not affect splicing (BP4). In summary, this variant meets the criteria to be classified as benign for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: BA1, BP4. -

Nov 01, 2019
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The NM_000018.3:c.478-22_478-21delCA (NP_000009.1:p.?) [GRCH38: NC_000017.11:g.7221516_7221517delCA] variant in ACADVL gene is interpretated to be Benign based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant meets the following evidence codes reported in the ACMG guidelines: BS1, BS2 -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.51
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60400822; hg19: chr17-7124834; API